Literature DB >> 10676704

Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs.

V Wenzel1, K H Lindner, A C Krismer, W G Voelckel, M F Schocke, W Hund, M Witkiewicz, E A Miller, G Klima, J Wissel, W Lingnau, F T Aichner.   

Abstract

OBJECTIVES: We sought to determine the effects of vasopressin and saline placebo in comparison with epinephrine on neurologic recovery and possible cerebral pathology in an established porcine model of prolonged cardiopulmonary resuscitation (CPR).
BACKGROUND: It is unknown whether increased cerebral blood flow during CPR with vasopressin is beneficial with regard to neurologic recovery or detrimental owing to complications such as cerebral edema after return of spontaneous circulation.
METHODS: After 4 min of cardiac arrest, followed by 3 min of basic life support CPR, 17 animals were randomly assigned to receive every 5 min either vasopressin (0.4, 0.4 and 0.8 U/kg; n = 6), epinephrine (45, 45 and 200 microg/kg; n = 6) or saline placebo (n = 5). The mean value +/- SEM of aortic diastolic pressure was significantly (p < 0.05) higher 90 s after each of three vasopressin versus epinephrine versus saline placebo injections (60 +/- 3 vs. 45 +/- 3 vs. 29 +/- 2 mm Hg; 49 +/- 5 vs. 27 +/- 3 vs. 23 +/- 1 mm Hg; and 50 +/- 6 vs. 21 +/- 3 vs. 16 +/- 3 mm Hg, respectively). After 22 min of cardiac arrest, including 18 min of CPR, defibrillation was attempted to achieve return of spontaneous circulation.
RESULTS: All the pigs that received epinephrine and saline placebo died, whereas all pigs on vasopressin survived (p < 0.05). Neurologic evaluation 24 h after successful resuscitation revealed only an unsteady gait in all vasopressin-treated animals; after 96 h, magnetic resonance imaging revealed no cerebral pathology.
CONCLUSIONS: During prolonged CPR, repeated vasopressin administration, but not epinephrine or saline placebo, ensured long-term survival with full neurologic recovery and no cerebral pathology in this porcine CPR model.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10676704     DOI: 10.1016/s0735-1097(99)00562-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

1.  Terlipressin versus adrenaline in an infant animal model of asphyxial cardiac arrest.

Authors:  Jesús López-Herce; Bárbara Fernández; Javier Urbano; Santiago Mencía; Maria J Solana; Jimena del Castillo; Antonio Rodríguez-Núñez; Jose M Bellón
Journal:  Intensive Care Med       Date:  2010-03-18       Impact factor: 17.440

Review 2.  Anesthesia in swine : optimizing a laboratory model to optimize translational research.

Authors:  D Pehböck; H Dietrich; G Klima; P Paal; K H Lindner; V Wenzel
Journal:  Anaesthesist       Date:  2015-01       Impact factor: 1.041

Review 3.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

4.  Current pharmacological advances in the treatment of cardiac arrest.

Authors:  Andry Papastylianou; S Mentzelopoulos
Journal:  Emerg Med Int       Date:  2011-11-20       Impact factor: 1.112

5.  Adrenaline and vasopressin for cardiac arrest.

Authors:  Judith Finn; Ian Jacobs; Teresa A Williams; Simon Gates; Gavin D Perkins
Journal:  Cochrane Database Syst Rev       Date:  2019-01-17

6.  Monitoring of immune activation using biochemical changes in a porcine model of cardiac arrest.

Authors:  A Amann; B Widner; J Rieder; H Antretter; G Hoffmann; V Mayr; H U Strohmenger; D Fuchs
Journal:  Mediators Inflamm       Date:  2001-12       Impact factor: 4.711

7.  Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: a observational cohort study.

Authors:  Stefek Grmec; Stefan Mally
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

8.  The physiologic response to rescue therapy with vasopressin versus epinephrine during experimental pediatric cardiac arrest.

Authors:  Julia C Slovis; Ryan W Morgan; William P Landis; Anna L Roberts; Alexandra M Marquez; Constantine D Mavroudis; Yuxi Lin; Tiffany Ko; Vinay M Nadkarni; Robert A Berg; Robert M Sutton; Todd J Kilbaugh
Journal:  Resusc Plus       Date:  2020-11-25

Review 9.  Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?

Authors:  Volker Wenzel; Karl H Lindner
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

10.  Vasopressin improves survival in a porcine model of abdominal vascular injury.

Authors:  Karl H Stadlbauer; Horst G Wagner-Berger; Anette C Krismer; Wolfgang G Voelckel; Alfred Konigsrainer; Karl H Lindner; Volker Wenzel
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.